•
Dec 31, 2023

Nkgen Biotech Q4 2023 Earnings Report

Total Revenue
$0
EPS
-$1.68
Previous year: -$0.14
+1100.0%
Gross Profit
-$300K
Previous year: -$15K
+1900.0%
Cash and Equivalents
$276K
Previous year: $117K
+135.9%
Free Cash Flow
-$6.91M
Previous year: -$568K
+1115.3%
Total Assets
$34.8M
Previous year: $16.3M
+112.9%

Nkgen Biotech

Nkgen Biotech